Brief: Bergenbio Provides Update On Bemcentinib's Involvement In Potential Treatment Of COVID-19 Pandemic
July 28 (Reuters) - Bergenbio ASA BGBIO.OL :
* UPDATE ON BEMCENTINIB'S INVOLVEMENT IN POTENTIAL TREATMENT OF COVID-19 PANDEMIC
* CONFIRMS CO IS IN LATE STAGE SET-UP PHASE TO SPONSOR AND CONDUCT A SIMILAR STUDY TO ACCORD
IN A
COUNTRY OF HIGH COVID-19 INCIDENCE
* UNIVERSITY HOSPITAL SOUTHAMPTON NHS TRUST HAS NOTIFIED ALL SITES IN ACCORD STUDY TO CEASE
RECRUITMENT OF NEW PATIENTS INTO TRIAL
Source text for Eikon: ID:nWkr9nwvwb
Further company coverage: BGBIO.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee